Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY: GS )

605.43 -0.07 (-0.01%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Goldman Sachs Group

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Goldman Sachs Reaffirms September Rate Cut Forecast, Downplays Fed's 'Hawkish Surprise'
Goldman Sachs reiterates forecast for 2 interest rate cuts in 2024, starting in Sept. Fed's June meeting showed progress on inflation, may lead to Sept. cut. 
Via Benzinga
Topics Economy
Exposures Interest Rates
DraftKings Stock Can Overcome 'Wall Of Worry Around Various Regulatory Risks' Analyst Says: Sizing Up Illinois Taxes, Jackpocket Acquisition
Higher taxes in Illinois and losses at Jackpocket could be short-term headwinds for DraftKings, but Goldman Sachs keeps the stock a Buy for future outlook. 
Via Benzinga
Wendy's Is A 'Show Me' Story, Goldman Sachs Analyst Says: Fast Food Joints Like Chipotle, Domino's Are Still Hot
Mixed results for restaurant company stocks in 2024, Goldman Sachs analyst optimistic about prominent brands in today's price tailwind environment. 
Via Benzinga
Goldman Sachs To Double Lending To Ultra-Wealthy Clients By 2029 As Part Of Wealth Management Expansion Strategy
Goldman Sachs Group plans to double its lending to ultra-wealthy private bank clients by 2029. This initiative is part of the bank's broader strategy to bolster its wealth management operations. 
Via Benzinga
(GS) - Analyzing Goldman Sachs Gr's Short Interest
Via Benzinga
Goldman Sachs Gr Unusual Options Activity
Via Benzinga
$100 Invested In Goldman Sachs Gr 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Buffett Boosts Stake, Triggers Options Boom in Occidental Stock
Buffett liked Occidental Petroleum for the coming oil cycle, however, Chesapeake offers investors a much better growth story 
Via MarketBeat
Goldman Sachs Analyst Reaffirms Buy on Rubrik Despite Quarterly Losses, Highlights Strong ARR Growth
Goldman Sachs analyst maintains Buy rating on Rubrik, with a $48 price target. Rubrik reported Q1 results and expects positive growth. 
Via Benzinga
Nike To Gain From Innovation Reacceleration And Strengthening Inventory Backdrop, Goldman Sachs Analyst Says
Goldman Sachs analyst Brooke Roach has reiterated a Buy rating on Nike with a target price of $118. Roach is optimistic about Nike's innovative strides, especially ahead of the F4Q earnings call... 
Via Benzinga
Topics Earnings
Exposures Financial
Goldman Sachs Analyst Questions Autodesk's Revenue Growth And Total Addressable Market Targets
Goldman Sachs analyst maintains Sell rating on AutoDesk Inc with lowered price target of $225. Believes company has strong competitive positioning and may achieve 40% operating margins in long term.... 
Via Benzinga
Consumer Outlook 'Healthy' As Labor Demand Points To Wage Growth: Goldman Sachs
Consumer outlook remains strong with higher wages and disposable income predicted, boosting spending. Goldman Sachs recommends consumer stocks. 
Via Benzinga
Exposures Labor
Why NextEra Energy Raises Forecast After Analyst Day
NextEra Energy raises forecast after Analyst Day. Goldman Sachs maintains Buy rating with $81 price target. 
Via Benzinga
Top 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?
The fastest-growing dividends in the S&P 500 are good buys, but that doesn't mean it's time to buy them now; only one is accelerating distribution growth. 
Via MarketBeat
Topics Stocks
Exposures US Equities
These Could Be the Next Monster AI Stock Splits After Nvidia
Nvidia's stock split is history, but investors should keep their eyes on these three AI stocks. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Reasons Why Apple Stock Ought to Remain in Your Basket
Apple remains among the top growth stocks in the market investors with a long-term time horizon may want to consider holding right now. 
Via InvestorPlace
Is Eli Lilly the Best Pharmaceutical Stock for You?
Eli Lilly is serving a market that may reach $100 billion. 
Via The Motley Fool
From Speculation to Millionaire-Makers: 3 Penny Stocks With Bright Futures
Penny stocks are surging with strategic expansions and tech advancements, promising substantial upside for savvy investors. 
Via InvestorPlace
Nvidia Stock Split Might Not Lead To Sustained Rally, But It Could Replace Intel In Dow Index
Goldman Sachs cautions against expecting sustained rally after Nvidia's 10-for-1 stock split. Past splits show minimal impact on shares and liquidity. 
Via Benzinga
Topics Stocks
Exposures US Equities
OpenAI IPO? New CFO Announcement Raises IPO Intrigue
Incoming CFO Sarah Friar has experience with IPOs and Wall Street credibility. She is co-chair of Stanford's Digital Economy Lab. 
Via InvestorPlace
Topics Economy Initial Public Offering
Exposures Economy Securities Market
Apple's AI Breakthroughs At WWDC 2024 Lead To Higher iPhone Sales Projections By Goldman Sachs
Goldman Sachs analysts optimistic about Apple's WWDC 24, citing strong AI features and OS updates driving product demand and revenue growth. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
How IZEA Worldwide (NASDAQ: IZEA) Is Leading The World Into The Creator Economy Era
How IZEA Worldwide (NASDAQ: IZEA) Is Leading The World Into The Creator Economy Era 
Via News Direct
Topics Economy
Exposures Economy
The 3 Most Undervalued Utility Stocks to Buy in June 2024
Utility stocks are grossly undervalued. Names such as GWRS, ENB and AEP stand out due to their dynamic attributes and valuation metrics. 
Via InvestorPlace
3 Capital Markets Stocks to Buy Hand Over Fist in June
Diversify your portfolio with these cheap stocks today. 
Via The Motley Fool
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform. 
Via Benzinga
The 3 Best Dow Stocks to Buy in June 2024
Discover the three best Dow stocks to buy in June 2024. Invest in these top-performing companies with strong fundamentals. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Ready to Rally: Ride These 3 Stocks to Dow 50K
The Dow 30 has underperformed in 2024 on a relative basis to the S&P 500. Nonetheless, there are Dow stocks to buy. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners. 
Via Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty. 
Via InvestorPlace
9 Financials Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.